During the past decade, DM Clinical Research conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 29 clinical trials were completed, i.e. on average, 42.6% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 28 clinical trials were completed. i.e. 60.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DM Clinical Research" #1 sponsor was "Pfizer" with 22 trials, followed by "ModernaTX, Inc." with 6 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "BioNTech SE" with 4 trials sponsored and "Satsuma Pharmaceuticals, Inc." with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DM Clinical Research" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Advaccine (Suzhou) Biopharmaceuticals Co., Ltd." with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "DM Clinical Research" are "Migraine" (9 trials), "Rheumatoid Arthritis" (5 trials), "Ulcerative Colitis" (5 trials), "COVID-19" (4 trials) and "Influenza, Human" (4 trials). Many other conditions were trialed in "DM Clinical Research" in a lesser frequency.

Most popular intervention types in "DM Clinical Research" are "Drug" (42 trials), "Biological" (30 trials), "Other" (10 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (43 trials), "Rimegepant" (6 trials), "Dihydroergotamine" (3 trials), "Guselkumab" (3 trials) and "13vPnC" (2 trials). Other intervention names were less common.

The vast majority of trials in "DM Clinical Research" are 70 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "DM Clinical Research". undefined are not yet recruiting, 15 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in DM Clinical Research, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in DM Clinical Research, 6 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".